Ipatia Emframidou
Directeur/Membre du Conseil chez Colonis Pharma Ltd.
Postes actifs de Ipatia Emframidou
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Colonis Pharma Ltd.
 Colonis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., Colonis Pharma Ltd. is a British pharmaceutical company that manufactures and supplies pharmaceutical products. The company is based in Weybridge, UK. The company was founded in 2005 by Thomas Engelen. Colonis Pharma was acquired by Quantum Pharma Holdings Ltd., part of Triley Bidco Ltd. from November 02, 2017 on September 30, 2012. | Directeur/Membre du Conseil | 11/08/2017 | - |
Historique de carrière de Ipatia Emframidou
Statistiques
Internationale
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Colonis Pharma Ltd.
Colonis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., Colonis Pharma Ltd. is a British pharmaceutical company that manufactures and supplies pharmaceutical products. The company is based in Weybridge, UK. The company was founded in 2005 by Thomas Engelen. Colonis Pharma was acquired by Quantum Pharma Holdings Ltd., part of Triley Bidco Ltd. from November 02, 2017 on September 30, 2012. | Health Technology |
- Bourse
- Insiders
- Ipatia Emframidou
- Expérience
